Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: The health, aging and body composition study

Sleep

Volumn 38, Issue 2, 2015, Pages 189-195

  Hall, Martica H ^a   Smagula, Stephen F ^b   Boudreau, Robert M ^b   Ayonayon, Hilsa N ^c   Goldman, Suzanne E ^b   Harris, Tamara B ^d   Naydeck, Barbara L ^b   Rubin, Susan M ^c   Samuelsson, Laura ^e   Satterfield, Suzanne ^f   Stone, Katie L ^g   Visser, Marjolein ^h   Newman, Anne B ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Epidemiology; Inflammation; Mortality; Sleep

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

AGED; AGING; ARTICLE; BODY COMPOSITION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH STATUS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; SLEEP PATTERN; SLEEP TIME; ANCESTRY GROUP; BLOOD; DEMOGRAPHY; INSOMNIA; LIFESTYLE; LONGITUDINAL STUDY; METABOLISM; PENNSYLVANIA; PHYSIOLOGY; SLEEP; SURVIVAL ANALYSIS; TENNESSEE; TIME FACTOR;

AGED; AGING; BIOMARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MORTALITY; PENNSYLVANIA; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVAL ANALYSIS; TENNESSEE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922020800     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4394     Document Type: Article

References (47)

1. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007;30:1659-66.
2. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964;54:11-23.
3. Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 2002;3:305-14.
4. Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep and mortality: a population-based 22-year follow-up study. Sleep 2007;30:1245-53.
5. Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 1979;36:103-16.
6. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
7. Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004;27:440-4.
8. Tamakoshi A, Ohno Y. Self-reported sleep duration as a predictor of allcause mortality: results from the JACC study, Japan. Sleep 2004;27:51-4.
9. Amagai Y, Ishikawa S, Gotoh T, et al. Sleep duration and mortality in Japan: the Jichi Medical School Cohort Study. J Epidemiol 2004;14:124-8.
10. Kojima M, Wakai K, Kawamura T, et al. Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol 2000;10:87-93.
11. Kaplan GA, Seeman TE, Cohen RD, Knudsen LP, Guralnik J. Mortality among the elderly in the Alameda County Study: behavioral and demographic risk factors. Am J Public Health 1987;77:307-12.
12. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585-92.
13. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res 2009;18:148-58.
14. Breslow L, Enstrom JE. Persistence of health habits and their relationship to mortality. Prev Med 1980;9:469-83.
15. Burazeri G, Gofin J, Kark JD. Siesta and mortality in a Mediterranean population: a community study in Jerusalem. Sleep 2003;26:578-84.
16. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 2003;132:24-31.
17. Marsik C, Kazemi-Shirazi L, Schickbauer T, et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008;54:343-9.
18. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)-No association with sleep duration or sleep disordered breathing. Sleep 2007;30:991-6.
19. Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun 2009;23:351-4.
20. Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep 2009;32:200-4.
21. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006;166:1756-62.
22. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun 2010;24:54-7.
23. Miller MA, Kandala NB, Kivimaki M, et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II Study. Sleep 2009;32:857-64.
24. Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev 2007;65:244-52.
25. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-83.
26. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007;30:1145-52.
27. van Leeuwen WM, Lehto M, Karisola P, et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PloS One 2009;4:e4589.
28. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012;16:137-49.
29. Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 2011;21:799-806.
30. Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2003;51:323-30.
31. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
32. Holmbeck GN. Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the childclinical and pediatric psychology literatures. J Consult Clin Psychol 1997;65:599-610
33. Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 2009;32:760-6.
34. Omisade A, Buxton OM, Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav 2010;99:651-6.
35. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-9.
36. Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endorinol Metab 2004;89:5762-71.
37. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endorinol Metab 1999;84:1979-85.
38. Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav Immun 2003;17:365-72.
39. Zhong X, Hilton HJ, Gates GJ, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appli Physiol 2005;98:2024-32.
40. Dettoni JL, Consolim-Colombo FM, Drager LF, et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol 2012;113:232-6.
41. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best practice & research. J Clin Endorinol Metab 2010;24:775-84.
42. Patel SR, Malhotra A, Gottlieb DJ, White DP, Hu FB. Correlates of long sleep duration. Sleep 2006;29:881-9.
43. Grandner MA, Kripke DF. Self-reported sleep complaints with long and short sleep: a nationally representative sample. Psychosom Med 2004;66:239-41.
44. Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of the literature. Progr Cardiovasc Nurs 2004;19:56-9.
45. Weiss A, Beloosesky Y, Boaz M, Yalov A, Kornowski R, Grossman E. Body mass index is inversely related to mortality in elderly subjects. J Gen Intern Med 2008;23:19-24.
46. Janssen I, Katzmarzyk PT, Ross R. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 2005;53:2112-8.
47. National Sleep Foundation. 2003 Sleep in America Poll. Washington, DC, 2003.